• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of familial Mediterranean fever with anakinra in patients unresponsive to colchicine.

作者信息

Pecher A-C, Igney-Oertel A, Kanz L, Henes J

机构信息

a Centre for Interdisciplinary Clinical Immunology, Rheumatology and Autoinflammatory Diseases and Department of Internal Medicine II , University Hospital Tübingen , Tübingen , Germany.

b Department of Hematology, Oncology, Immunology, Rheumatology, Pulmonology , University Hospital Tübingen , Tübingen , Germany.

出版信息

Scand J Rheumatol. 2017 Sep;46(5):407-409. doi: 10.1080/03009742.2016.1245780. Epub 2017 Jan 18.

DOI:10.1080/03009742.2016.1245780
PMID:28097903
Abstract
摘要

相似文献

1
Treatment of familial Mediterranean fever with anakinra in patients unresponsive to colchicine.对秋水仙碱无反应的家族性地中海热患者使用阿那白滞素进行治疗。
Scand J Rheumatol. 2017 Sep;46(5):407-409. doi: 10.1080/03009742.2016.1245780. Epub 2017 Jan 18.
2
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.白细胞介素-1抑制剂在合并淀粉样变性的家族性地中海热患者中的疗效与安全性。
Mod Rheumatol. 2019 Mar;29(2):363-366. doi: 10.1080/14397595.2018.1457469. Epub 2018 Apr 27.
3
[Anakinra in a case of fever familial Mediterranean].[阿那白滞素治疗一例家族性地中海热发热]
Farm Hosp. 2014 Sep 16;38(5):446-8. doi: 10.7399/fh.2014.38.5.7555.
4
Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial.家族性地中海热中秋水仙碱治疗失败及潜在替代方案：启动阿那白滞素试验
Isr Med Assoc J. 2014 May;16(5):271-3.
5
Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.抗白细胞介素-1治疗对秋水仙碱耐药的家族性地中海热患儿的疗效与安全性
Pediatr Int. 2023 Jan-Dec;65(1):e15588. doi: 10.1111/ped.15588.
6
Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.评估阿那白滞素和卡那单抗对秋水仙碱耐药/无反应的家族性地中海热患者的疗效。
Adv Rheumatol. 2020 Jan 30;60(1):12. doi: 10.1186/s42358-020-0117-1.
7
Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.26例难治性家族性地中海热患者的抗白细胞介素-1治疗
Mod Rheumatol. 2017 Mar;27(2):350-355. doi: 10.1080/14397595.2016.1194510. Epub 2016 Jun 22.
8
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.模仿狼疮发作的家族性地中海热：一种自身免疫性疾病与自身炎症性疾病的罕见共存。
J Clin Rheumatol. 2018 Mar;24(2):104-106. doi: 10.1097/RHU.0000000000000636.
9
Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment.卡那单抗作为传统治疗难治性家族性地中海热的挽救疗法。
Drug Des Devel Ther. 2015 Apr 17;9:1983-7. doi: 10.2147/DDDT.S69117. eCollection 2015.
10
Factors Associated With Successful Withdrawal of Biologic Agents in Children With Colchicine-Resistant Familial Mediterranean Fever.与秋水仙碱耐药性家族性地中海热儿童成功停用生物制剂相关的因素。
J Clin Rheumatol. 2024 Oct 1;30(7):257-263. doi: 10.1097/RHU.0000000000002118. Epub 2024 Sep 3.

引用本文的文献

1
The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever.单次阿那白滞素注射在儿童家族性地中海热疾病发作时的疗效。
Rheumatol Int. 2024 Nov;44(11):2569-2575. doi: 10.1007/s00296-023-05351-0. Epub 2023 Jun 6.
2
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.托珠单抗治疗家族性地中海热——一项随机、双盲、安慰剂对照的II期研究
J Clin Med. 2022 Sep 13;11(18):5360. doi: 10.3390/jcm11185360.
3
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
遗传性复发性发热中白细胞介素-1 阻断剂的实际适应证：来自 JIRcohort 的数据和文献复习。
Front Immunol. 2021 Nov 11;12:744780. doi: 10.3389/fimmu.2021.744780. eCollection 2021.
4
Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever.家族性地中海热中的淀粉样变性和肾小球疾病。
Medicina (Kaunas). 2021 Oct 1;57(10):1049. doi: 10.3390/medicina57101049.
5
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies.原发性免疫缺陷诊断中的免疫与遗传学：处于变革之门的研究
Diagnostics (Basel). 2021 Mar 16;11(3):532. doi: 10.3390/diagnostics11030532.
6
[Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].[作为儿科和青少年风湿病学会以及德国风湿病学会“对秋水仙碱反应不足或不耐受的家族性地中海热患者的循证治疗建议”依据的系统文献检索结果]
Z Rheumatol. 2020 Nov;79(9):943-951. doi: 10.1007/s00393-020-00886-0. Epub 2020 Sep 30.
7
The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.白介素-1 抑制剂在家族性地中海热患者中的应用：一篇叙述性综述。
Front Immunol. 2020 May 28;11:971. doi: 10.3389/fimmu.2020.00971. eCollection 2020.
8
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).关于难治性家族性地中海热（FMF）的管理进展。
Orphanet J Rare Dis. 2019 Oct 15;14(1):224. doi: 10.1186/s13023-019-1201-7.
9
[Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].[家族性地中海热的循证治疗建议：儿科与青少年风湿病学会和德国风湿病学会联合声明]
Z Rheumatol. 2019 Feb;78(1):91-101. doi: 10.1007/s00393-018-0588-1.
10
A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever.一种新的伴有嗜中性皮肤病的与 Pyrin 相关的自身炎症突变进一步明确了 Pyrin 的 14-3-3 结合以及与家族性地中海热的区别。
Ann Rheum Dis. 2017 Dec;76(12):2085-2094. doi: 10.1136/annrheumdis-2017-211473. Epub 2017 Aug 23.